Flow Traders U.S.’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Flow Traders U.S.’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,378	Closed	-$432K	–	1000
2026 Q1	$432K	Buy	+10,378	New	+$425K	0.01%	700
2022 Q2	–	Sell	-18,961	Closed	-$530K	–	811
2022 Q1	$530K	Sell	18,961 -7,525	-28%	-$223K	0.02%	539
2021 Q4	$1.02M	Sell	26,486 -14,838	-36%	-$633K	0.05%	285
2021 Q3	$1.89M	Buy	41,324 +30,846	+294%	+$1.44M	0.08%	287
2021 Q2	$523K	Buy	+10,478	New	+$513K	0.03%	581

Other funds holding BBC

KCP

Kera Capital Partners San Jose, California $1.04B AUM 52.56% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

MCM

Militia Capital Management Austin, Texas $3.37B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

QCM

Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Flow Traders U.S.'s BBC Position: Q2 2026 in Review

Flow Traders U.S. sold out of Virtus Biotech Clinical Trials ETF (BBC) in Q2 2026, closing a stake of 10,378 shares — an estimated $432K sold.

Flow Traders U.S. first reported a position in BBC in Q2 2021 and held it in 5 quarters. The position peaked at $1.89M in Q3 2021. 20 funds tracked by Wall St. Rank hold BBC as of Q2 2026.

Flow Traders U.S. reported no remaining Virtus Biotech Clinical Trials ETF position as of Q2 2026 after selling out during the quarter.
Flow Traders U.S. sold 10,378 Virtus Biotech Clinical Trials ETF shares in Q2 2026, an estimated $432K.
Flow Traders U.S. first reported a position in Virtus Biotech Clinical Trials ETF in Q2 2021 and held it in 5 quarters.
Flow Traders U.S.'s Virtus Biotech Clinical Trials ETF position peaked at $1.89M in Q3 2021.
20 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q2 2026.

Based on Flow Traders U.S.'s 13F filing for Q2 2026, filed 14 Aug 2026.